Stocktoria
Leef Brands Inc. LEEEF
OTC · OOTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2013-04-17
Leef Brands Inc. financials (annual, from 10-K)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $34.8M | $28.5M |
| Gross profit | $10.5M | $7.7M |
| R&D expense | $19,696 | $18,983 |
| Operating income | -$7.6M | -$8.0M |
| Income tax | $2.5M | $3.3M |
| Net income | -$17.6M | -$24.6M |
| EPS (diluted) | $-0.10 | $-0.17 |
| Operating cash flow | -$336,895 | -$1.0M |
| Free cash flow | -$978,909 | -$7.0M |
| Cash & equivalents | $2.2M | $2.7M |
| Inventory | $3.4M | $4.2M |
| Total assets | $36.4M | $43.0M |
| Total liabilities | $44.7M | $55.4M |
| Shareholders' equity | -$8.3M | -$12.4M |
Growth · year-over-year · Revenue CAGR 22.1%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | +22.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001711141 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.